PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC10653547::ACT002678

MAP-0403_J-2

Evidence text

Paper-level observation

Table 4: K. pneumoniae ATCC BAA-1706, pH 8, MAP-0403 J-2 MIC 16 μg/mL
tableConfidence: medium

Assay observation

Activity
Antimicrobial
Subtype
Antibacterial
Measure
MIC
Comparator
=
Raw observation
16.0 μg/mL
Normalized measurement
=16 µg/mL
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Klebsiella pneumoniae
Assay method
Not reported by source
Sequence
KWLRRPWRRWRNH
Standardization
ready simple

Source publication

Synergistic effect of two antimicrobial peptides, BP203 and MAP-0403 J-2 with conventional antibiotics against colistin-resistant Escherichia coli and Klebsiella pneumoniae clinical isolates.

PLOS ONE · 2023

DOI 10.1371/journal.pone.0294287 PMC10653547
Parent mention

Related peptide identities

PEPDIA-PLP-001674

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.